SCOTT JOHN K JR. purchased 3.26K shares of NAVIDEA BIOPHARMACEUTICALS, INC. on the open market
Open‑market purchases signal personal conviction.
P · 1 purchase
Filed: 5/3/2022ACC: 0001437749-22-010726
10% Owner
Since Sep 2018
-42.50K
Net shares
Net seller
$0.00
Total acquired
1
Open market trades
1B · 0S
4
Total transactions
7.50K acquired · 50K disposed
Non-Derivative Transactions2
Series G Redeemable Preferred Stock
Direct
Shares
+3.26K
Price / share
—
Trade value
—
% of position
New position
4/10/2022
0.00→3.26K
Common Stock
Direct
Shares
+2.50K
Price / share
—
Trade value
—
% of position
0.0%
4/30/2022
8.09M→8.09M
Total
Net shares
+5.76K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Series G Redeemable Preferred Stock Direct | 4/10/2022 | P · Purchase | +3.26K | — | — | New position | 0.00 | 3.26K |
| Common Stock Direct | 4/30/2022 | A · Award | +2.50K | — | — | 0.0% | 8.09M | 8.09M |
| Total | +5.76K | $0.00 | ||||||
Derivative Transactions2
Series E Redeemable Convertible Preferred Stock
Direct
Converts to
Common Stock
2.17M shares
Shares
−50K
Strike price
2.30
Held after
0.00
Exercisable
—
4/10/2022
Series F Redeemable Convertible Preferred Stock
Direct
Converts to
Common Stock
2.17M shares
Shares
+1.74K
Strike price
0.80
Held after
1.74K
Exercisable
—
4/10/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series E Redeemable Convertible Preferred Stock Direct | Common Stock2.17M shares | 4/10/2022 | S · Sale | −50K | 2.30 | — | 0.00 |
| Series F Redeemable Convertible Preferred Stock Direct | Common Stock2.17M shares | 4/10/2022 | P · Purchase | +1.74K | 0.80 | — | 1.74K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned10.14K
Total
10.14K indirect10.14K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 10.14K | Indirect |
| Total | 10.14K | 10.14K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported